- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Cost Aside, Rheumatoid Arthritis Drugs Have Similar Effect
Rheumatoid arthritis patients who were treated with a more costly treatment, saw no more improvement than those sought conventional treatment in reducing time off work.
Rheumatoid arthritis patients who were treated with a more costly treatment, saw no more improvement than those sought conventional treatment in reducing time off work. US News reports:
Treatment with a pricey biological drug was no better than cheaper, conventional therapy in terms of reducing time off from work for people with rheumatoid arthritis, a new study finds.
Swedish researchers assessed lost work days among rheumatoid arthritis patients who had not responded to initial treatment with a standard medication, methotrexate.
The group of 204 patients were randomly given either the biological drug infliximab (Remicade) or conventional combination therapy with the non-biologics sulfasalazine plus hydroxychloroquine.
Read the full story here: http://bit.ly/12Bc1hh
